Nov 11, 2026Pilot program validates continuous manufacturing platform | Curia adds fermentation capacity

Nov 10, 2026DoD removes WuXi AppTec from 1260H List | Samsung must invest to compete with Lonza

Nov 7, 2026Pfizer’s $650M manufacturing center | Phillips Medisize acquires entire footprint of UK site

Nov 6, 2026FDA’s potency assurance strategy for CGT | Samsung’s PolyPeptide deal moves forward

Nov 5, 2026Stevanato’s 2027 GLP-1 reduction | Shilpa CDMO invests $50M in peptide manufacturing

Nov 4, 2026Lonza to buy 5 US sites from Merck KGaA | AGC inks dual-site deal with global pharma

Nov 3, 2026Charles River’s CDMO business gets new owner | Fresenius, WuXi’s biosimilars deal

Oct 31, 2026Recipharm completes refinancing, moves HQ | Cambrex breaks ground on $120M expansion

Oct 30, 2026Extended reality and workforce training | Lonza to boost bioconjugation at Swiss site

Oct 29, 2026Lonza to fill US bioconjugation gap | Made Scientific, CARR scale cell therapy manufacturing

Oct 28, 2026WuXi AppTec raises revenue forecast | Ardena invests in new compaction simulator

Oct 27, 2026Radiopharma growth outpaces infrastructure | Regeneron extends Ebola treatment deal

Oct 24, 2026Lonza-Samsung rivalry heats up | Esteve CDMO invests $80M in China site

Oct 23, 2026Making yeast fermentation more efficient | Lilly breaks ground on $5B Virginia site

Oct 22, 2026Samsung Biologics continues growth trajectory | Samsung Bioepis nabs Brazilian deal

Oct 21, 2026Lonza’s AI strategy shows early results | Sanofi starts construction on German insulin plant

Oct 20, 2026Sanofi wins Facility of the Year Award | Cell Therapies, S2N.Bio tech transfer

Oct 17, 2026Lonza says it is well-positioned for growth | Kindeva secures $226M DLA contract

Oct 16, 2026Lonza’s Vacaville upgrades progressing per plan | Recipharm expands high potency offering

Oct 15, 2026Minnesota CDMO quadruples capacity | Charles River, Magellan team on stem cells

Oct 14, 2026India’s pharma industry looks beyond US | UCB’s $2B Georgia campus takes shape

Oct 13, 2026CDMOs at CPHI Milan say outsourced demand is strong | GSK’s $800M PA expansion

Oct 10, 2026Manufacturers adapt amid myriad of pressures | Robotics biomanufacturing startup raises $75M

Oct 9, 2026Thermo Fisher boosts manufacturing capacity | Alvotech, Lotte ink long-term partnership

Oct 8, 2026GLP-1 demand challenges pharma manufacturers | Olon boosts ADC platform in France

Latest Edition